Complex sentence: Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the U.S. It has been an FDA approved treatment for schizophrenia since 2010 and for treating depressive episodes in adults with bipolar I disorder since 2013.
Split into simpler sentences: Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the USA. Lurasidone is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia since 2010 and depressive episodes associated with bipolar I disorder since 2013.